Vnitr Lek 2017, 63(11):821-833 | DOI: 10.36290/vnl.2017.155

Non-CF bronchiectasis of adults: short review for clinical practice. Position paper of Board of disease with bronchial obstruction Czech Pulmonological and Phthiseological Society Czech Medical Association of J. E. Purkyne

Zuzana Antušová^1,2, Libor Fila³, Vladimír Herout⁴, Eva Kočová⁵, Kateřina Neumannová⁶, Jaromír Zatloukal⁷, Vladimír Koblížek^2,*

¹ Plicní ambulance, GEPAMED - NEXTCLINIC, Hradec Králové

² Plicní klinika LF UK a FN Hradec Králové

³ Pneumologická klinika 2. LF UK a FN v Motole, Praha

⁴ Klinika nemocí plicních a tuberkulózy LF MU a FN Brno, pracoviště Bohunice

⁵ Radiologická klinika LF UK a FN Hradec Králové

⁶ Katedra fyzioterapie Fakulty tělesné kultury UP v Olomouci

⁷ Klinika plicních nemocí a tuberkulózy LF UP a FN Olomouc

Bronchiectasis is a clinically important, but poorly understood, pulmonary condition characterized by dilated and thick-walled bronchi. Bronchiectasis remains a significant cause of morbidity and mortality around the world. Targeted effort to early high-resolution computed tomography diagnosis and detailed confirmation of causation are in the spotlight of respiratory physicians in the developed countries. The risk population consists of subjects with persistent and/or productive cough, where another clear diagnosis has not been performed. Specific treatment tailored on underlying diseases and non-specific airway clearance techniques are able to improve symptoms, and reduce lung impairment. Evidence-based treatment algorithms for anti-inflammatory, and antibiotic treatment of stable non-CF BE will have to await large-scale, long-term controlled studies. Surgery should be reserved for individuals with highly symptomatic, localized bronchiectasis who have failed medical management. Unfortunately, there have been few well designed longitudinal or cross-sectional studies in the field of bronchiectasis. To give truly meaningful and generalizable results, a longitudinal observational study of bronchiectasis would require to enrol several thousand patients, more than any one center can enrol. The European Bronchiectasis Registry will create an open, pan-European registry of patients with non-CF bronchiectasis. The authors emphatically recommend that all respiratory specialist managed non-CF BE subjects should be actively involved in the European Bronchiectasis Registry.

Keywords: bronchiectasis; diagnosis; registry; treatment

Received: September 17, 2017; Accepted: September 26, 2017; Published: November 1, 2017  Show citation